China artificial tears market is estimated to grow considerably at a CAGR of around 5.2% during the forecast period. China has been anticipated to witness considerable growth in the artificial tears market due to a considerable rise in the aging population in the country. According to the State Council of the People’s Republic of China, the country had over 230.8 million people with the age of 60 or more in 2016. It represents 16.7% of the overall population in China. Among these people, nearly 150 million people aged 60 or over, which is 10.8% of the overall population. According to the United Nations (UN), China will take 20 years to double the proportion of the elderly population from 10% to 20% during the period (2017-2037).
In 2016, China had adopted a 13th 5-year national plan for eye health (2016-2020). Under this plan, the supporting measures are taken at all levels by Health and Family Planning Commissions that are focused on putting significant attention to eye disease treatment and prevention. In addition, it involves promoting eye health awareness and set up a favorable environment for eye care. Around 90% of the counties have medical care institutes of eye health and of which 90% can perform cataract procedure. This plan is focused on appointing new personnel for the treatment of eye diseases. Such government initiatives may lead to encourage healthcare infrastructure for eye treatment, which in turn, is expected to fuel the adoption of artificial tears for the treatment of dry eye diseases.
The companies which are contributing to the growth of China artificial tears market include Carl Zeiss Meditec AG, Allergan PLC, Johnson & Johnson Services, Inc., Nidek Co., Ltd., and Santen Pharmaceutical Co., Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Research Methodology
The market study of the China artificial tears market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for drug manufacturers, healthcare providers, government organizations for overall market analysis, and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segment
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. China Artificial Tears Market by Type
5.1.1. Cellulose Derived Tears
5.1.2. Glycerin Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.2. China Artificial Tears Market by Delivery Method
5.2.1. Artificial Eye Drops
5.2.2. Ointments
5.3. China Artificial Tears Market by Application
5.3.1. Dry Eyes Treatment
5.3.2. Contact Lens Moisture
5.3.3. Others
6. Company Profiles
6.1. Allergan PLC
6.2. Bausch & Lomb Inc.
6.3. Carl Zeiss Meditec AG
6.4. Johnson & Johnson Services, Inc.
6.5. Nicox S.A.
6.6. Nidek Co., Ltd.
6.7. OCuSOFT, Inc.
6.8. Santen Pharmaceutical Co., Ltd.
6.9. STAAR Surgical Co.
6.10. Topcon Corp.
1. CHINA ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. CHINA ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2018-2025 ($ MILLION)
3. CHINA ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. CHINA ARTIFICIAL TEARS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. CHINA ARTIFICIAL TEARS MARKET SHARE BY DELIVERY METHOD, 2018 VS 2025 (%)
3. CHINA ARTIFICIAL TEARS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)